• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗环瓜氨酸肽抗体在幼年特发性关节炎成年患者中的应用。

Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.

机构信息

Evangelical University Hospital of Curitiba, Paraná, Brazil.

出版信息

J Clin Rheumatol. 2011 Dec;17(8):421-3. doi: 10.1097/RHU.0b013e31823a4d0a.

DOI:10.1097/RHU.0b013e31823a4d0a
PMID:22089992
Abstract

BACKGROUND

Antibodies to cyclic citrullinated peptide (anti-CCP) have been found in different proportions in the juvenile idiopathic arthritis (JIA) population. The majority of studies have been done in children or mixed population (children plus adults).

AIM

The objective of the study was to study the prevalence of anti-CCP in JIA adult patients.

METHODS

Anti-CCP3 was searched for in 49 adult patients with JIA and associated with clinical and demographics data. As comparisons, 156 patients with adult rheumatoid arthritis (RA) and 100 healthy volunteers were studied.

RESULTS

Nine patients (18.3%) were positive for anti-CCP3. All of them had the polyarthritis form. This antibody was more common in JIA than in control subjects (P = 0.0002) and less common in JIA than in adult RA patients (P < 0.0001), but the rheumatoid factor polyarticular form of JIA had the same prevalence as in adult RA patients (P = 0.33).In JIA patients, anti-CCP had a positive association with the presence of rheumatoid factor (P < 0.0001), worse functional status (P = 0.04), need for orthopedic surgery (P = 0.01), and later disease onset (P = 0.0007).

CONCLUSIONS

In adult patients with JIA, the prevalence of anti-CCP3 is 18%, and its presence may define a sample of patients with worse prognosis.

摘要

背景

抗环瓜氨酸肽(anti-CCP)抗体在幼年特发性关节炎(JIA)人群中存在不同比例。大多数研究是在儿童或混合人群(儿童加成人)中进行的。

目的

本研究旨在研究成年 JIA 患者中抗 CCP 的患病率。

方法

在 49 名成年 JIA 患者中搜索抗 CCP3,并与临床和人口统计学数据相关联。作为对照,研究了 156 名成年类风湿关节炎(RA)患者和 100 名健康志愿者。

结果

9 名患者(18.3%)抗 CCP3 阳性。他们均为多关节炎型。该抗体在 JIA 患者中比在对照组中更为常见(P = 0.0002),在 JIA 患者中比在成年 RA 患者中更为少见(P < 0.0001),但 JIA 多关节炎型类风湿因子的患病率与成年 RA 患者相同(P = 0.33)。在 JIA 患者中,抗 CCP 与类风湿因子的存在呈正相关(P < 0.0001),功能状态更差(P = 0.04),需要矫形手术(P = 0.01),以及发病较晚(P = 0.0007)。

结论

在成年 JIA 患者中,抗 CCP3 的患病率为 18%,其存在可能定义了预后较差的患者群体。

相似文献

1
Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.抗环瓜氨酸肽抗体在幼年特发性关节炎成年患者中的应用。
J Clin Rheumatol. 2011 Dec;17(8):421-3. doi: 10.1097/RHU.0b013e31823a4d0a.
2
Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.青少年特发性关节炎患者血清中抗环瓜氨酸肽抗体的测定。
J Rheumatol. 2004 Sep;31(9):1829-33.
3
Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.幼年特发性关节炎患者的抗环瓜氨酸肽抗体
Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057.
4
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.年龄对多关节型幼年特发性关节炎中抗瓜氨酸化蛋白/肽抗体患病率的影响。
Rheumatology (Oxford). 2006 Feb;45(2):204-8. doi: 10.1093/rheumatology/kei133. Epub 2005 Sep 27.
5
Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.幼年特发性关节炎患儿的抗环瓜氨酸肽(抗CCP)抗体
J Rheumatol. 2003 Apr;30(4):825-8.
6
Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.抗环瓜氨酸肽抗体在幼年特发性关节炎中的诊断准确性
Ann Rheum Dis. 2004 Dec;63(12):1687-9. doi: 10.1136/ard.2003.019331.
7
Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.在单纯性和多发性多关节起病的幼年类风湿关节炎中,抗环瓜氨酸肽抗体与HLA - DR4相关。
Arthritis Rheum. 2005 Jan;52(1):239-46. doi: 10.1002/art.20773.
8
Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.抗环瓜氨酸肽抗体在幼年特发性关节炎和类风湿关节炎患者中的表达:固有自身反应性 9G4 独特型的共同表达。
Arthritis Rheumatol. 2017 Jul;69(7):1387-1395. doi: 10.1002/art.40117. Epub 2017 Jun 5.
9
The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.在中国类风湿关节炎患者中,HLA - DRB1共享表位与抗环瓜氨酸肽抗体无关。
Scand J Rheumatol. 2008 May-Jun;37(3):183-7. doi: 10.1080/03009740701874444.
10
Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.对于类风湿因子阴性的幼年特发性关节炎患者,检测抗环瓜氨酸肽抗体可能有益。
Clin Rheumatol. 2016 Mar;35(3):601-7. doi: 10.1007/s10067-015-2971-5. Epub 2015 May 21.

引用本文的文献

1
Clinical, Immunological and Inflammatory Characteristics among Mexican Children with Different Subtypes of Juvenile Idiopathic Arthritis: Exploring the Correlation between Anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF).不同亚型幼年特发性关节炎墨西哥儿童的临床、免疫和炎症特征:探讨抗环瓜氨酸肽(anti-CCP)与类风湿因子(RF)之间的相关性
Pediatr Rep. 2024 Feb 7;16(1):151-162. doi: 10.3390/pediatric16010014.
2
Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.自身抗体在幼年特发性关节炎发病机制、诊断和预后中的作用。
Front Immunol. 2019 Jan 14;9:3168. doi: 10.3389/fimmu.2018.03168. eCollection 2018.
3
Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis.
幼年特发性关节炎患儿的抗环瓜氨酸肽抗体
Electron Physician. 2016 Sep 20;8(9):2897-2903. doi: 10.19082/2897. eCollection 2016 Sep.
4
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis.Meta 分析:抗环瓜氨酸肽抗体对幼年特发性关节炎的诊断准确性。
J Immunol Res. 2015;2015:915276. doi: 10.1155/2015/915276. Epub 2015 Feb 19.
5
Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.抗环瓜氨酸肽抗体在系统性红斑狼疮患者中的研究:巴西患者的横断面研究。
Clin Rheumatol. 2013 Jul;32(7):1065-70. doi: 10.1007/s10067-013-2213-7. Epub 2013 Feb 15.